Latest call day: 2026-08-25 · full consensus board · graded history
Price (daily close, 2026-08-24)
Today's calls AI
| Biotech · Meta-Ensemble | UP 100% | Meta-Ensemble — a blend of this domain's strategies weighted by their recent precision. REGN ranks #1 of 8 in Biotech (100% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · OBV Trend | UP 100% | OBV Trend — on-balance-volume accumulation. REGN ranks #1 of 8 in Biotech (100% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · SOTA Ensemble | UP 100% | SOTA Ensemble — a purged-CV rank ensemble (gradient-boosting + ridge + momentum). REGN ranks #1 of 8 in Biotech (100% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · LightGBM | UP 86% | LightGBM — a gradient-boosted model fit on this basket's recent features. REGN ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Low Volatility | UP 86% | Low Volatility — the low-volatility anomaly. REGN ranks #2 of 8 in Biotech (86% bullish percentile, annualized volatility 29%), so the agent calls it UP for the next session. |
| Biotech · Mean-Reversion | UP 86% | Mean-Reversion — contrarian on the trailing return. REGN ranks #2 of 8 in Biotech (86% bullish percentile, recent move +2.9%, fading it), so the agent calls it UP for the next session. |
| Biotech · Momentum | UP 86% | Momentum — trailing return (trend-following). REGN ranks #2 of 8 in Biotech (86% bullish percentile, signal +24.3%), so the agent calls it UP for the next session. |
| Biotech · Regime Switch | UP 86% | Regime Switch — the market looks trending, so it ranked on Momentum. REGN ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · RSI Mean-Reversion | DOWN 86% | RSI Mean-Reversion — oversold up / overbought down. REGN ranks #4 of 8 in Biotech (86% bearish percentile, RSI 75), so the agent calls it DOWN for the next session. |
| Biotech · Trend Strength | UP 86% | Trend Strength — OLS slope of log price. REGN ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · MACD | UP 71% | MACD — MACD histogram momentum crossover. REGN ranks #3 of 8 in Biotech (71% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Donchian | UP 57% | Donchian — position within the Donchian channel. REGN ranks #4 of 8 in Biotech (57% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Volume Thrust | UP 29% | Volume Thrust — volume-confirmed accumulation. REGN ranks #6 of 8 in Biotech (29% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Momentum Acceleration | UP 14% | Momentum Acceleration — trend speeding up. REGN ranks #7 of 8 in Biotech (14% bullish percentile, signal -18.5%), so the agent calls it UP for the next session. |
Best agents on REGN (graded record)
| Mean-Reversion Agent | 100% | 1/1 correct | DOWN |
| Biotech · 52-Week-High | 70% | 7/10 correct | UP |
| Biotech · Breakout | 64% | 16/25 correct | UP |
| Biotech · Momentum | 61% | 22/36 correct | UP |
| Biotech · OBV Trend | 61% | 14/23 correct | UP |
| Biotech · Donchian | 61% | 20/33 correct | UP |
| Biotech · Momentum Acceleration | 57% | 23/40 correct | UP |
| Biotech · MACD | 57% | 23/40 correct | UP |
| Biotech · Long-Term Reversal | 54% | 13/24 correct | UP |
| Biotech · Vol-Adjusted Momentum | 50% | 11/22 correct | UP |
Recent news
| 2026-08-24 | Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLP · pr_newswire_finance |
| 2026-08-21 | Oil Shipper Hits New High; Three Stocks Also Near Pivots · yf_tkr_REGN |
| 2026-08-21 | Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGN · pr_newswire_finance |
| 2026-08-20 | N-PX - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer) · sec_edgar_current |
| 2026-08-20 | REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action - Contact SueWallSt · pr_newswire_finance |
| 2026-08-20 | Regeneron Secures FDA Approval for Rare Genetic Disorder Drug · yf_tkr_REGN |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。